SUMMARY The presence of autoimmune diseases and autoantibodies has been studied in 237 individuals from 17 families with two or more members affected by rheumatoid arthritis (RA). Hyperthyroidism occurred significantly more frequently than in a local control population (p<005), but if the RA cases were excluded this significance was lost. Thyroid cytoplasmic and microsomal antibodies were significantly more common (p<0-001), and this remained true if RA sufferers were excluded (p<0-01). The prevalence of both clinical thyroid disease and circulating thyroid autoantibodies was similar in the families where RA was associated with HLA-DR4 and in those where no DR4 association was observed. RA and immune thyroid disease may, therefore, share a common inherited factor, but this is unlikely to be at the HLA-DR locus. Antinuclear factor (ANF) was found in association with RA and with HLA-DR3 within the RA group (p<0-02). Relatives of RA sufferers did not show any excess of ANF positivity. The prevalence of pernicious anaemia (PA) and gastric parietal cell antibody did not differ from the expected.
Both familial clustering of RA and an association with the major histocompatibility complex (MHC) antigen, HLA-DR4, are well recognised.' Despite these observations, the role of inheritance in the aetiology of RA remains unclear. Susceptibility to RA may be specific to that disease or part of a common autoimmune disease susceptibility. In the latter case this could allow the development of different autoimmune diseases depending upon trigger factors or on other inherited factors. If this is the case then autoimmune disorders and autoantibodies should be found in higher frequency in the relatives of RA sufferers. A recent family study of RA2 has shown that in those families where RA was not inherited with DR4 there was a high incidence of autoimmune thyroid disease in the non-arthritic relatives (five out of seven families). The authors' interpretation of this observation is that RA can be inherited with HLA-DR4 or it can be separately Acccpted for publication 20 Table 2 summarises the results of the autoantibodies found in the family population. Thyroid cytoplasmic and thyroid microsomal antibodies were found in increased frequency, as compared with the Whickham population. This excess remained if the RA sufferers were excluded (Table 3) . Of the five families in which RA was inherited with a non-DR4 haplotype, four had relatives with thyroid autoantibodies compared with nine of the 12 DR4 positive haplotype families. ANF was found in increased numbers, but if the RA group was excluded the prevalence was the same as in the Whickham survey (i.e., 5%). Thyroid autoantibodies were found to be associated with HLA-DR8 in this population. This association was retained if RA was excluded. As this was an unexpected association it may be the result of a secondary statistical error, and a further study would be necessary to confirm or refute this. ANF was significantly associated with HLA-DR3 in the whole population (p<0001), and this association is sufficiently strong to exclude a secondary statistical error. The association of ANF with DR3 occurred in the RA group, where six of the 12 RA sufferers positive for ANF possessed DR3 compared with five of the 39 ANF negative RA individuals (p<0-01). There was no association of DR3 with non-RA ANF positivity. HLA-DR7 was found significantly less frequently in the ANF positive group. Gastric parietal cell positivity in the non-RA group was weakly associated with HLA-DR7.
Within the family population the 'RA haplotypes' were not significantly associated with any autoimmune disease except RA. Similarly, no association was found with the autoantibodies except for ANF, and this association was lost if RA was excluded.
Discussion
Autoimmune diseases are well recognised as occurring more frequently together than could be expected by chance.8 One possible explanation for this is the inheritance of a common gene predisposing to autoimmunity, the type of disease developed depending on other factors either inherited or environmental. The inheritance of many autoimmune diseases with the HLA-B8-Dw3-DR3 haplotype9 is in favour of this. The association of RA with HLA-DR4 is evidence against RA being included in this common inheritance. An increase of thyroid disease in the families of RA sufferers has, however, previously been reported,2 though this was only in families in which RA was inherited with a haplotype not containing HLA-DR4. The increased prevalence of hyperthyroidism in our families was dependent upon its occurrence with RA. The hyperthyroidism did not occur more frequently in the 'non-DR4' families in our study and if our data are added to those of Grennan et al.2 the association with 'non-DR4' families is lost. Hypothyroidism was not found in excess and cannot therefore be included in this shared inheritance.
The prevalence of thyroid microsomal and cytoplasmic antibodies was greatly increased in the family population by comparison with the Whickham population, and this excess was independent of an association with RA. The data from the Whickham survey suggest that thyroid autoantibodies are related to thyroid disease. They are found in association with both hyperthyroidism and hypothyroidism. The finding of an increase of thyroid autoantibodies in the relatives of RA sufferers therefore supports a common inherited factor for both RA and immune thyroid disease.
Previous studies have shown different HLA associations for RA and autoimmune thyroid disease; RA being associated with HLA-DR4 and autoimmune thyroid disease with HLA-DR3. "' Therefore, it would seem likely that any common inherited factor is not at the DR locus. This is supported by our observation that thyroid disease and thyroid autoantibodies were not associated with the 'RA haplotype', and it is likely that any common inherited factor is not in the MHC. PA 
